CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $99K of Crinetics Pharmaceuticals, Inc.
Sold$98,610
$32.87Price
3,000Shares
−4%Stake
What CRNX did after the filing
- The stock from Wed, Dec 13 close, $34.43
- +9.5%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Jan 29 close.
Traded Mon, Dec 11. Filed Wed, Dec 13, 11:44 AM ET, during the session. Returns use the Dec 13 close and the Jan 29 close. Not investment advice.